In the present study, we have demonstrated that the
fruiting bodies of WBM have significant antihyperglycemic
and antihypercholesterolemic activities in rats. The
mushroom did not affect the concentration of plasma
cholesterol but did lower plasma TG, ALT, and AST levels
in diabetic rats. In hypercholesterolemic rats fed ABP, the
reduction of plasma cholesterol is associated with the rise
and the fall of plasma HDL and LDL levels, respectively.
The mushroom also significantly lowered liver cholesterol
and TG levels. In addition, the hypocholesterolemic effects
of WBM were associated with lower atherogenic index and
cardiac risk factor.